• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高脂饮食导致蛋白质 O-GlcNAc 修饰减少和线粒体缺陷,促进阿尔茨海默病特征的发展。

High-Fat Diet Leads to Reduced Protein O-GlcNAcylation and Mitochondrial Defects Promoting the Development of Alzheimer's Disease Signatures.

机构信息

Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, 00185 Rome, Italy.

Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

出版信息

Int J Mol Sci. 2021 Apr 3;22(7):3746. doi: 10.3390/ijms22073746.

DOI:10.3390/ijms22073746
PMID:33916835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8038495/
Abstract

The disturbance of protein O-GlcNAcylation is emerging as a possible link between altered brain metabolism and the progression of neurodegeneration. As observed in brains with Alzheimer's disease (AD), flaws of the cerebral glucose uptake translate into reduced protein O-GlcNAcylation, which promote the formation of pathological hallmarks. A high-fat diet (HFD) is known to foster metabolic dysregulation and insulin resistance in the brain and such effects have been associated with the reduction of cognitive performances. Remarkably, a significant role in HFD-related cognitive decline might be played by aberrant protein O-GlcNAcylation by triggering the development of AD signature and mitochondrial impairment. Our data support the impairment of total protein O-GlcNAcylation profile both in the brain of mice subjected to a 6-week high-fat-diet (HFD) and in our in vitro transposition on SH-SY5Y cells. The reduction of protein O-GlcNAcylation was associated with the development of insulin resistance, induced by overfeeding (i.e., defective insulin signaling and reduced mitochondrial activity), which promoted the dysregulation of the hexosamine biosynthetic pathway (HBP) flux, through the AMPK-driven reduction of GFAT1 activation. Further, we observed that a HFD induced the selective impairment of O-GlcNAcylated-tau and of O-GlcNAcylated-Complex I subunit NDUFB8, thus resulting in tau toxicity and reduced respiratory chain functionality respectively, highlighting the involvement of this posttranslational modification in the neurodegenerative process.

摘要

蛋白质 O-GlcNAc 修饰的紊乱似乎是大脑代谢改变与神经退行性病变进展之间的一个可能联系。正如在阿尔茨海默病 (AD) 大脑中观察到的那样,大脑葡萄糖摄取的缺陷会转化为蛋白质 O-GlcNAc 修饰的减少,从而促进病理性特征的形成。高脂肪饮食 (HFD) 已知会促进大脑代谢失调和胰岛素抵抗,并且这种影响与认知表现下降有关。值得注意的是,异常的蛋白质 O-GlcNAc 修饰可能通过触发 AD 特征和线粒体损伤在 HFD 相关认知能力下降中发挥重要作用。我们的数据支持高脂肪饮食(HFD)处理 6 周的小鼠大脑和我们在 SH-SY5Y 细胞中的体外转位中总蛋白质 O-GlcNAc 修饰谱的损伤。蛋白质 O-GlcNAc 修饰的减少与过食引起的胰岛素抵抗(即胰岛素信号缺陷和线粒体活性降低)有关,这促进了己糖胺生物合成途径(HBP)通量的失调,通过 AMPK 驱动的 GFAT1 激活减少。此外,我们观察到 HFD 诱导 O-GlcNAc 化 tau 和 O-GlcNAc 化 Complex I 亚基 NDUFB8 的选择性损伤,分别导致 tau 毒性和呼吸链功能降低,突出了这种翻译后修饰在神经退行性过程中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/ab2c3ab70ffe/ijms-22-03746-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/ccf7f6619340/ijms-22-03746-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/874c2f1bc5b3/ijms-22-03746-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/3d1c19985b1b/ijms-22-03746-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/9587b1fa4455/ijms-22-03746-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/1f9d7e146120/ijms-22-03746-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/fe9ef91354da/ijms-22-03746-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/7af7407b846f/ijms-22-03746-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/be5d400740a8/ijms-22-03746-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/ab2c3ab70ffe/ijms-22-03746-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/ccf7f6619340/ijms-22-03746-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/874c2f1bc5b3/ijms-22-03746-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/3d1c19985b1b/ijms-22-03746-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/9587b1fa4455/ijms-22-03746-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/1f9d7e146120/ijms-22-03746-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/fe9ef91354da/ijms-22-03746-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/7af7407b846f/ijms-22-03746-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/be5d400740a8/ijms-22-03746-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6af/8038495/ab2c3ab70ffe/ijms-22-03746-g009.jpg

相似文献

1
High-Fat Diet Leads to Reduced Protein O-GlcNAcylation and Mitochondrial Defects Promoting the Development of Alzheimer's Disease Signatures.高脂饮食导致蛋白质 O-GlcNAc 修饰减少和线粒体缺陷,促进阿尔茨海默病特征的发展。
Int J Mol Sci. 2021 Apr 3;22(7):3746. doi: 10.3390/ijms22073746.
2
Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.阿尔茨海默病中 O-GlcNAcylation 的减少与线粒体异常强烈相关。
Biochim Biophys Acta Mol Basis Dis. 2019 Aug 1;1865(8):2048-2059. doi: 10.1016/j.bbadis.2018.10.037. Epub 2018 Nov 6.
3
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.阿尔茨海默病三转基因小鼠模型中改变的蛋白质 O-GlcNAc 修饰的蛋白质组学鉴定。
Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3309-3321. doi: 10.1016/j.bbadis.2018.07.017. Epub 2018 Jul 18.
4
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome.OGT/OGA 循环失调介导唐氏综合征中的 Tau 和 APP 神经病理学。
Neurotherapeutics. 2021 Jan;18(1):340-363. doi: 10.1007/s13311-020-00978-4. Epub 2020 Nov 30.
5
Consumption of a high fat diet promotes protein O-GlcNAcylation in mouse retina via NR4A1-dependent GFAT2 expression.高脂肪饮食通过 NR4A1 依赖性 GFAT2 表达促进小鼠视网膜中蛋白的 O-GlcNAc 化。
Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3568-3576. doi: 10.1016/j.bbadis.2018.09.006. Epub 2018 Sep 11.
6
Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.O-连接的N-乙酰葡糖胺修饰减少与阿尔茨海默病中较低的脑葡萄糖代谢及tau蛋白病变相关。
Brain. 2009 Jul;132(Pt 7):1820-32. doi: 10.1093/brain/awp099. Epub 2009 May 18.
7
Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.阿尔茨海默病小鼠模型海马 Tau 蛋白 O-糖基化与磷酸化失衡的证据。
Pharmacol Res. 2016 Mar;105:186-97. doi: 10.1016/j.phrs.2016.01.006. Epub 2016 Jan 24.
8
O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.O-糖基化乙酰化作为阿尔茨海默病的治疗靶点。
Neuromolecular Med. 2020 Jun;22(2):171-193. doi: 10.1007/s12017-019-08584-0. Epub 2020 Jan 1.
9
Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain.代谢应激改变抗氧化系统,抑制脂联素受体 1,并诱导小鼠大脑出现类似阿尔茨海默病的病变。
Cells. 2020 Jan 19;9(1):249. doi: 10.3390/cells9010249.
10
O-GlcNAc modification in diabetes and Alzheimer's disease.糖尿病和阿尔茨海默病中的O-连接N-乙酰葡糖胺修饰
Mol Biosyst. 2007 Nov;3(11):766-72. doi: 10.1039/b704905f. Epub 2007 Aug 29.

引用本文的文献

1
Enhancing protein O-GlcNAcylation in down syndrome mice mitigates memory dysfunctions through the rescue of mitochondrial bioenergetics, stress responses and pathological markers.增强唐氏综合征小鼠的蛋白质O-连接N-乙酰葡糖胺化可通过挽救线粒体生物能量学、应激反应和病理标志物来减轻记忆功能障碍。
Redox Biol. 2025 Jul 16;85:103769. doi: 10.1016/j.redox.2025.103769.
2
Multiple Mechanisms and Therapeutic Strategies for the Involvement of AMPK in the Development of Alzheimer's Disease.AMPK参与阿尔茨海默病发生发展的多种机制及治疗策略
Mol Neurobiol. 2025 Jul 15. doi: 10.1007/s12035-025-05162-3.
3
Protein O-GlcNAcylation in reproductive biology and the impact of metabolic disease.

本文引用的文献

1
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome.OGT/OGA 循环失调介导唐氏综合征中的 Tau 和 APP 神经病理学。
Neurotherapeutics. 2021 Jan;18(1):340-363. doi: 10.1007/s13311-020-00978-4. Epub 2020 Nov 30.
2
Inhibition of 37/67kDa Laminin-1 Receptor Restores APP Maturation and Reduces Amyloid-β in Human Skin Fibroblasts from Familial Alzheimer's Disease.抑制37/67kDa层粘连蛋白-1受体可恢复家族性阿尔茨海默病患者皮肤成纤维细胞中淀粉样前体蛋白的成熟并减少β淀粉样蛋白
J Pers Med. 2020 Nov 16;10(4):232. doi: 10.3390/jpm10040232.
3
Insulin mediated novel therapies for the treatment of Alzheimer's disease.
生殖生物学中的蛋白质O-连接N-乙酰葡糖胺化修饰以及代谢性疾病的影响
Hum Reprod Update. 2025 Jun 26. doi: 10.1093/humupd/dmaf013.
4
Epigenetic Explorations of Neurological Disorders, the Identification Methods, and Therapeutic Avenues.神经紊乱的表观遗传学探索、鉴定方法和治疗途径。
Int J Mol Sci. 2024 Oct 30;25(21):11658. doi: 10.3390/ijms252111658.
5
Biliverdin Reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3β.胆红素还原酶-A 通过磷酸化 GSK3β 将胰岛素信号与线粒体代谢整合在一起。
Redox Biol. 2024 Jul;73:103221. doi: 10.1016/j.redox.2024.103221. Epub 2024 Jun 1.
6
Changes in transcriptomic landscape with macronutrients intake switch are independent from O-GlcNAcylation levels in heart throughout postnatal development in rats.在大鼠出生后的整个发育过程中,随着常量营养素摄入转换而发生的转录组格局变化独立于心脏中的O-连接N-乙酰葡糖胺化水平。
Heliyon. 2024 Apr 30;10(9):e30526. doi: 10.1016/j.heliyon.2024.e30526. eCollection 2024 May 15.
7
O-GlcNAc of STING mediates antiviral innate immunity.STING 的 O-GlcNAc 修饰介导抗病毒先天免疫。
Cell Commun Signal. 2024 Mar 1;22(1):157. doi: 10.1186/s12964-024-01543-8.
8
Diet-inducing hypercholesterolemia show decreased O-GlcNAcylation of liver proteins through modulation of AMPK.饮食诱导的高胆固醇血症通过调节AMPK导致肝脏蛋白质的O-连接N-乙酰葡糖胺糖基化减少。
J Physiol Biochem. 2024 Feb;80(1):205-218. doi: 10.1007/s13105-023-00997-7. Epub 2023 Nov 24.
9
Nutritional and metabolic control of germ cell fate through O-GlcNAc regulation.通过 O-GlcNAc 调控对生殖细胞命运进行营养和代谢控制。
EMBO Rep. 2023 Nov 6;24(11):e56845. doi: 10.15252/embr.202356845. Epub 2023 Oct 16.
10
Mitochondrial heterogeneity in diseases.疾病中的线粒体异质性。
Signal Transduct Target Ther. 2023 Aug 23;8(1):311. doi: 10.1038/s41392-023-01546-w.
胰岛素介导的阿尔茨海默病治疗新策略。
Life Sci. 2020 May 15;249:117540. doi: 10.1016/j.lfs.2020.117540. Epub 2020 Mar 10.
4
APP Maturation and Intracellular Localization Are Controlled by a Specific Inhibitor of 37/67 kDa Laminin-1 Receptor in Neuronal Cells.APP 成熟和细胞内定位受神经元细胞中 37/67 kDa 层粘连蛋白-1 受体特定抑制剂的控制。
Int J Mol Sci. 2020 Mar 4;21(5):1738. doi: 10.3390/ijms21051738.
5
Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.慢性高血糖通过下调体内和体外 OGT 相关的 O-GlcNAc 化诱导 tau 过度磷酸化。
Brain Res Bull. 2020 Mar;156:76-85. doi: 10.1016/j.brainresbull.2020.01.006. Epub 2020 Jan 10.
6
O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.O-糖基化乙酰化作为阿尔茨海默病的治疗靶点。
Neuromolecular Med. 2020 Jun;22(2):171-193. doi: 10.1007/s12017-019-08584-0. Epub 2020 Jan 1.
7
High-Fat Diet Induces Neuroinflammation and Mitochondrial Impairment in Mice Cerebral Cortex and Synaptic Fraction.高脂饮食诱导小鼠大脑皮层和突触部分发生神经炎症和线粒体损伤。
Front Cell Neurosci. 2019 Nov 12;13:509. doi: 10.3389/fncel.2019.00509. eCollection 2019.
8
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives.靶向阿尔茨海默病中的线粒体:原理与展望。
CNS Drugs. 2019 Oct;33(10):957-969. doi: 10.1007/s40263-019-00658-8.
9
Dysfunction of mitochondria: Implications for Alzheimer's disease.线粒体功能障碍:对阿尔茨海默病的影响。
Int Rev Neurobiol. 2019;145:13-27. doi: 10.1016/bs.irn.2019.03.001. Epub 2019 Mar 26.
10
Acute increases in -GlcNAc indirectly impair mitochondrial bioenergetics through dysregulation of LonP1-mediated mitochondrial protein complex turnover.-GlcNAc 的急剧增加通过失调 LonP1 介导的线粒体蛋白复合物周转间接损害线粒体生物能学。
Am J Physiol Cell Physiol. 2019 Jun 1;316(6):C862-C875. doi: 10.1152/ajpcell.00491.2018. Epub 2019 Mar 13.